Active · per the CBE, 16 November 2026

DALUPHAR

BE0860093852

Rechtspersoon Public limited company 1 establishment

DALUPHAR is a pharmacy in Anderlecht. Public Limited, started on 14 August 2003, 1 establishment.

Edmond Delcourtstraat 53, 1070 Anderlecht

Active for

23 year, 3 months

Financials

Financial year 2025

DALUPHAR from Anderlecht, company number BE0860093852, closed financial year 2025 with a result of € -30,135 after tax. For that financial year DALUPHAR recorded a gross margin of € 271,824 and equity of € 74,439. Compared with financial year 2023, the result moved from € 11,493 to € -30,135. The company made a loss. The buffer shrank hard: equity is 60 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Shrank hard

€ 74,439

▼ 60% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -30,135

▼ still € 11,493 profit in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 20,226

▼ 87% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -87,561.

People and assets in 2025

Full-time equivalents

4.3

▲ 2.2 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 293,874

▲ 69% vs 2023

€ 68,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,263

▼ 86% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go

€ 17,603

▼ 32% vs 2023

€ 15,379 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 425,822

▲ 270% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 60,648

▲ 106% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
2021202220232025Change 2023 → 2025
Gross margin € 222,513 € 198,348 € 201,069 € 271,824 ▲ 35%
Profit after taxes € 7,201 € -49,612 € 11,493 € -30,135 ▼ € 41,629
Equity € 222,970 € 173,359 € 184,852 € 74,439 ▼ 60%
Total debts € 246,509 € 270,011 € 287,730 € 576,925 ▲ 101%
Cash € 100,140 € 101,518 € 160,197 € 20,226 ▼ 87%
Retained profit € 60,970 € 11,359 € 22,852 € -87,561 ▼ € 110,412
Bank debt € 31,966 € 36,651 € 25,773 € 17,603 ▼ 32%
Balance sheet total € 469,480 € 443,369 € 472,581 € 651,365 ▲ 38%
Employees (FTE) 2.7 3.1 2.1 4.3 ▲ 2.2

By gross margin, DALUPHAR ranks 11th of 52 companies with main activity “Detailhandel in farmaceutische producten” in Anderlecht that publish figures (fiscal year 2025).

Key figures of DALUPHAR, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DALUPHAR?

What happened at DALUPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 30,135 (▼ € 41,629 vs 2023). filed late Source: NBB ↗
  • New establishment in Anderlecht. KBO
  • Start of the company according to the CBE. KBO

In short

From € 7,201 profit in 2021 to € 30,135 loss in 2025.

Paid € 4,891 in corporate taxes since 2021.

Best year ever: 2023, with € 11,493 profit.

On average € 63,200 of value added per employee in 2025.

Establishments

Establishment units

Physical locations of this company

Registered office

Edmond Delcourtstraat 53

1070 Anderlecht

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Anderlecht

Same main activity (Detailhandel in farmaceutische producten), 57 active companies in Anderlecht, largest first.

Multipharma

€ 580.8 million revenue · 2025

Popelin Apotheken

€ 152.2 million revenue · 2025

Les Pharmaciens Associés

€ 16.9 million revenue · 2025

Horus Pharma Belux

€ 1.9 million gross margin · 2024

"WESTLAND PHARMA"

€ 914,402 gross margin · 2025

PHARMACIE LAURENT DELCOURT

€ 870,107 gross margin · 2026

Details

Company number
0860.093.852
VAT number
BE 0860.093.852
Registered office
Edmond Delcourtstraat 53, 1070 Anderlecht
Names & denominations
DALUPHAR
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
14 August 2003
Peppol
Active · Active since 1 Jan 2001
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Frequently asked questions

What does DALUPHAR do?
DALUPHAR is a pharmacy in Anderlecht. Public Limited, started on 14 August 2003, 1 establishment.
What is the address of DALUPHAR?
The registered office of DALUPHAR is located at Edmond Delcourtstraat 53, 1070 Anderlecht.
Is DALUPHAR still active?
Yes. According to the CBE (16 November 2026) DALUPHAR is active, legal situation “Normale toestand”, started on 14 August 2003.
Is DALUPHAR registered on Peppol?
Yes, DALUPHAR is registered on the Peppol network with ID 0208:0860093852.
What is the enterprise number of DALUPHAR?
The enterprise number of DALUPHAR is BE0860093852.
When was DALUPHAR founded?
DALUPHAR was founded on 14 August 2003.